Let's connect

Want to discuss your project or have any questions?

GMP manufacturing of non-sterile dosage forms

Non-sterile GMP production

Our GMP facilities support clinical trial supplies manufacturing up to 50 kg. We offer manufacturing for topical liquids and semi-solids, oral liquids powder in capsules and powders in bottles. Additionally, we provide primary packaging services for capsules and tablets, to help ensure high-quality production for clinical studies.

A scientist wearing a labcoat is weighing raw materials under a laminar flow hood

Liquids and semi-solids manufacturing up to 50kg

We operate two GMP manufacturing platforms: 

  • A 10 kg compounding tank with a 5 kg melting vessel.
  • A 50kg compounding tank with a 25 kg melting vessel.

These platforms allow manufacturing of creams, gels, ointments, lotions, solutions and suspensions. We provide primary packaging services, including filling into amber glass bottles, plastic bottles, aluminum tubes and plastic tubes. 

Nuvisan offers 390 m² of cGMP facilities, with four manufacturing rooms, three filling rooms, an in-process control laboratory and a dedicated cleaning area. All these rooms are monitored in temperature, relative humidity (hygrometry) and pressure. Our facilities are designed for the safe handling of highly potent APIs (OEL >1 µg/m³) and botanical materials. 

Capsules manufacturing

Nuvisan provides manual encapsulation for early-phase development, preparing capsule formulations using HPMC or gelatine capsule shells. Capsules are filled with drug substances or with excipient, utilising a capsule board for simple formulations. Activities cover compatibility studies (API and excipients), scale-up batches, stability studies and internal pharmaceutical analytical support. Services also include over-encapsulation for clinical or home administration.

Powder in bottles 

Powder in bottle: This option is suitable when the API is soluble in water, the administration volume is acceptable and administration is conducted at the clinic. Nuvisan manages the development of the reconstitution procedure and in-use stability studies. 

Two-bottle system: This option is suitable when administration occurs at the clinic and additional excipients are required for API solubilisation or suspension. Nuvisan manages the development of the diluent, including stability, the development of the reconstitution procedure and in-use stability studies. 

Contact us

Nuvisan is committed to protecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Talk to us

talk icon
+49 731 9840 0 

Our locations

location icon

Neu-Ulm (headquarters)

Wegenerstrasse 13

89231 Neu-Ulm

Germany

Berlin

Muellerstrasse 178

13353 Berlin

Germany

Sophia Antipolis

2400 route des Colles

06410 Biot

France

Grafing

Am Feld 32

85567 Grafing

Germany

Waltrop

Im Wirrigen 25

45731 Waltrop

Germany

For concerns about pharmaceuticals or adverse drug-related events, contact us at: complaints@nuvisan.com